Cargando…
Pregnancy outcomes after exposure to interferon beta: a register-based cohort study among women with MS in Finland and Sweden
BACKGROUND: Our aim was to estimate and compare the prevalence of adverse pregnancy outcomes among pregnant women with multiple sclerosis (MS) exposed to interferon beta (IFNB) and among women with MS unexposed to any MS disease-modifying drug (MSDMD). METHODS: This cohort study used Finnish (1996–2...
Autores principales: | Hakkarainen, Katja Marja, Juuti, Rosa, Burkill, Sarah, Geissbühler, Yvonne, Sabidó, Meritxell, Popescu, Catrinel, Suzart-Woischnik, Kiliana, Hillert, Jan, Artama, Miia, Verkkoniemi-Ahola, Auli, Myhr, Kjell-Morten, Mehtälä, Juha, Bahmanyar, Shahram, Montgomery, Scott, Korhonen, Pasi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549181/ https://www.ncbi.nlm.nih.gov/pubmed/33101459 http://dx.doi.org/10.1177/1756286420951072 |
Ejemplares similares
-
The association between exposure to interferon-beta during pregnancy and birth measurements in offspring of women with multiple sclerosis
por: Burkill, Sarah, et al.
Publicado: (2019) -
The Incidence and Predisposing Factors of John Cunningham Virus-Induced Progressive Multifocal Leukoencephalopathy in Southern Finland: A Population-Based Study
por: Kartau, Marge, et al.
Publicado: (2019) -
Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patients
por: Verkkoniemi-Ahola, Auli, et al.
Publicado: (2023) -
Progressive Multifocal Leukoencephalopathy: Current Insights
por: Kartau, Marge, et al.
Publicado: (2019) -
Serological response to nifurtimox in adult patients with chronic Chagas disease: An observational comparative study in Argentina
por: Vizcaya, David, et al.
Publicado: (2021)